Mirabegron ER

Drug Details

Mirabegron, marketed under the brand name Myrbetriq, is a medication prescribed to address bladder issues, specifically overactive bladder (OAB) in adults and neurogenic detrusor overactivity (NDO) in children aged 3 years and older. These conditions often lead to frequent urination, urgent needs to urinate that are difficult to manage, and involuntary urination (incontinence). Mirabegron functions by relaxing the detrusor muscle in the bladder, a process that allows the bladder to store more urine, thereby reducing the frequency of urination and easing the symptoms associated with these bladder conditions. It is typically administered orally once a day, and is available in tablet form or as granules for suspension. Some common side effects may include high blood pressure, symptoms of a common cold, and urinary tract infections. There is currently no generic version of this medication available. Always consult with a healthcare professional before starting any new medication to ensure it is appropriate for your health needs.